The AFP levels increase in patients with active hepatitis or cirrhosis, while low levels of AFP are correlated with a good response to nucleos(t)ide analogs in chronic hepatitis B [17] or to direct-acting antivirals (DAA) treatment for chronic hepatitis C [19]. This evidence concerns the gene AFP and Cirrhosis.